First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Those with atopic dermatitis have lower resistance to the herpes infection. What is Eczema Herpeticum?

Eczema 52

Eczema Dermatitis Clinic Medical 52

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A. The study appears in Dermatitis.

Treatments 77

Treatments Dermatitis Therapy Safety 77

The Dermatology Digest

AUGUST 13, 2024

Drawing upon their 2016 discovery that the interferon response is constantly activated in people with Down syndrome, researchers designed the trial to focus on the autoimmune and inflammatory skin conditions that are common in people with Down syndrome including alopecia areata, psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Clinic 74

Clinic Safety Dermatitis Medical 74

The Dermatology Digest

FEBRUARY 26, 2024

Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the JAK inhibitors).

Treatments 74

Treatments Dermatitis Pharmaceutical Clinic 74

The Dermatology Digest

JANUARY 22, 2024

s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. Arcutis Biotherapeutics, Inc.’s

Dermatitis 78

Dermatitis Treatments Innovations Clinic 78

The Dermatology Digest

JANUARY 4, 2024

Smoking is known to increase the risk of developing atopic dermatitis (AD), even in adolescents. Furthermore, adolescents who use e-cigarettes are at increased risk of developing the “atopic march” consisting of the triad of asthma, atopic dermatitis, and allergic and allergic rhinitis compared to non-smokers,” the study authors write.

Dermatitis 69

Dermatitis Dermatology Medical Education 69

The Dermatology Digest

JANUARY 14, 2024

People with seborrheic dermatitis who don’t use topical steroids are 3.5 The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. Zoryve foam; 48.3% of the total study population).

Dermatitis 72

Dermatitis Dermatology Office Safety 72

The Dermatology Digest

FEBRUARY 8, 2024

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. It is the first drug approved for seborrheic dermatitis with a new mechanism of action in over two decades. in seborrheic dermatitis. in seborrheic dermatitis.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

AUGUST 23, 2024

Janus kinase (JAK) inhibitors have had game-changing effects for patients with psoriasis, atopic dermatitis, vitiligo, and alopecia areata, but the use of these potent medications has been associated with JAK inhibitor-associated acne (JAKne). Dr. Friedman agrees.

Dermatology 74

Dermatology Dermatitis Medical Clinic 74

The Dermatology Digest

FEBRUARY 12, 2024

Alys believes that emerging indications such as atopic dermatitis, vitiligo, alopecia areata and chronic spontaneous urticaria, will see the next breakthroughs in dermatological advancements. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.

Pharmaceutical 74

Pharmaceutical Technology Dermatology Medical 74

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

FEBRUARY 1, 2024

Atopy patch tests (APTs) may be the best way to detect food‐triggered atopic dermatitis (AD), according to a new literature review in Clinical Reviews in Allergy & Immunology. APTs detect sensitization to food proteins responsible for systemic contact dermatitis (SCD), which can then be confirmed by oral food challenge.

Dermatitis 36

Dermatitis Eczema Medical Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has given its nod to topical roflumilast foam (Zoryve, Arcutis) for seborrheic dermatitis. The PDE4 inhibitor is the first topical treatment for seborrheic dermatitis with a new mechanism of action in more than 20 years. in seborrheic dermatitis. This a a chronic disease,” he says. “We

Dermatitis 36

Dermatitis Safety Clinic Medical 36

The Dermatology Digest

SEPTEMBER 13, 2024

Flare is commonly used in eczema care and clinical research, but there’s been little agreement on what it means until now. The latest results from the study have been published in the Journal of the American Medical Association Dermatology. What is an eczema flare?

Eczema 36

Eczema Dermatitis Clinic Dermatology 36

First Derm

JULY 2, 2024

Online Dermatologist Sweating and Eczema: How to Manage Flare-Ups Eczema and Sweat | Symptoms of eczema | Physiology | How Sweating Affects Eczema | Triggers for Eczema | Related conditions | Managing Sweat to Prevent Eczema Flare-Ups | Treatment Key Takeaways Eczema, particularly atopic dermatitis, flares up with triggers like sweat.

Eczema 59

Eczema Management Dermatitis Irritation 59

The Dermatology Digest

JULY 10, 2024

for use in moderate to severe atopic dermatitis (AD) in the NHS England. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab. The National Institute for Health and Care Excellence (NICE) now recommends lebrikizumab (Ebglyss, Almirall S.A.)

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

The Dermatology Digest

MARCH 9, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, discusses the role that abrocitinib (Cibinqo, Pfizer) and upadacitinib (Rinvoq, AbbVie) play in treating patients with atopic dermatitis (AD). Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis 36

Dermatitis Eczema Dermatology Clinic 36

The Dermatology Digest

MARCH 9, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, discusses the role that abrocitinib (Cibinqo, Pfizer) and upadacitinib (Rinvoq, AbbVie) play in treating patients with atopic dermatitis (AD). Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis 36

Dermatitis Eczema Dermatology Clinic 36

The Dermatology Digest

MARCH 11, 2024

Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 10, 2024

More than two-thirds of people with atopic dermatitis (AD) and darker skin tones treated with lebrikizumab showed improvements in skin clearance and itch relief, according to late-breaking results from a Phase 3 study are being presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego.

Skin Types 36

Skin Types Fitzpatrick Scale Dermatitis Safety 36

The Dermatology Digest

FEBRUARY 26, 2024

Impairment in tight junction expression has been shown to contribute to the barrier dysfunction observed in patients with atopic dermatitis. 3 Emollient enhancement, neonatal moisturizer, and barrier lipid replacement have all been discussed as epithelial barrier-protecting agents that may treat and possibly even prevent atopic dermatitis.

Dermatitis 74

Dermatitis Irritation Therapy Dermatology 74

The Dermatology Digest

AUGUST 13, 2024

FDA The approval is based on positive results from the phase III OLYMPIA clinical trials – the largest clinical trial program conducted in this condition to date – in which nemolizumab demonstrated significant and clinically meaningful improvements in itch and skin nodules at Week 16, with rapid reductions in itch observed as early as Week 4.

Dermatitis 36

Dermatitis Safety Clinic Dermatology 36

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, shares pearls on keeping pediatric patients comfortable during common dermatologic procedures.

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

The Dermatology Digest

JANUARY 14, 2024

The overwhelming majority of people with atopic dermatitis (AD) treated with investigational roflumilast cream 0.15% (Zoryve, Arcutis) showed a measurable improvement in Eczema Area and Severity Index (EASI) in 4 weeks, according to new pooled analyses from two Phase 3 studies.

Dermatitis 36

Dermatitis Safety Dermatology Hospital 36

First Derm

DECEMBER 28, 2023

When to Consult a Doctor : Understand the importance of professional medical advice for severe cases or when self-care measures are insufficient. Eczema Eyelid Dermatitis: Reddish Patches and Inflammation Characteristic of Eczema Eczema refers to skin conditions characterized by redness, swelling, scaling, oozing/weeping, and/or dryness.

Treatments 45

Treatments Eczema Dermatitis Skin Health 45

First Derm

APRIL 5, 2024

The Challenge of Adherence in Dermatology Concept of Adherence Adherence in dermatology refers to the extent to which patients follow their prescribed treatment plans, including medication usage, skincare routines, and lifestyle modifications.

Dermatology 59

Dermatology Treatments Education Medical 59

The Dermatology Digest

DECEMBER 18, 2023

Air pollution may contribute to the development or worsening of skin conditions such as atopic dermatitis and eczema, according to researchers out of Massachusetts General Hospital (MGH). Carbon monoxide concentrations that were an average of 0.22 ppm in the months of May–September in 2019–2022 rose to 0.6 ppm in July of 2023.

Eczema 36

Eczema Dermatitis Hospital Dermatology 36

First Derm

DECEMBER 4, 2023

Dry skin is a very common problem in people with atopic dermatitis, a chronic inflammatory skin condition characterized by patches of itchy, dry, red, and inflamed skin. Atopic dermatitis (eczema) characterized by itchy patches of red, inflamed, dry skin. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Dry Skin 92

Dry Skin Moisturization Eczema Dermatitis 92

The Dermatology Digest

MARCH 11, 2024

Joshua Zeichner, MD, Associate Professor of Dermatology at the Mount Sinai Hospital in New York City, reviews the latest information on prescribing and monitoring isotretinoin for patients with severe nodulocystic acne and provides an update on the potential risks associated with this medication. Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

JANUARY 29, 2024

Hilary Baldwin, MD, the Medical Director of the Acne Treatment & Research Center in Morristown, NJ, shares why she is so excited about Cabtreo (clindamycin phosphate 1.2%/adapalene adapalene 0.15%/benzoyl peroxide, Ortho Dermatologics) and how she is planning to use it in her practice. Watch Now What is Urticaria?

Rosacea 36

Rosacea Dermatitis Hospital Dermatology 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

JANUARY 7, 2024

Led by Louisville, KY dermatologist Joe Fowler, MD, and George Martin, MD, a dermatologist in Kihei, HI, and Maui Derm Program Chairman, the four-day meeting will feature treatment updates on psoriasis, atopic dermatitis, acne/rosacea, pigmentation disorders, blistering diseases, pediatric dermatology and more. Surgeon General Boris D.

Dermatitis 36

Dermatitis Dermatology Rosacea Hospital 36

The Dermatology Digest

MARCH 8, 2024

Patients with AA have a high unmet medical need due to comorbid conditions and high impact on quality of life. The most common comorbid conditions associated with AA include vitiligo, atopic dermatitis, Hashimoto’s thyroiditis, psoriasis, and systemic lupus erythematosus. and Canada.

Dermatitis 36

Dermatitis Rosacea Dermatology Medical 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).

Treatments 36

Treatments Dermatitis Dermatology Eczema 36

The Dermatology Digest

DECEMBER 18, 2023

New practice parameters from the Joint Task Force for Practice Parameter) recommend the use of topical corticosteroids or topical calcineurin inhibitors in patients with uncontrolled atopic dermatitis (AD) despite moisturizer use. Urge consideration for once-daily dosing of topical medications. Suggest against elimination diets for AD.

Dermatitis 36

Dermatitis Partnerships Therapy Safety 36

The Dermatology Digest

MARCH 9, 2024

Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. Mark Lebwohl, MD, Dean for Clinical Therapeutics and Waldman Professor and Chairman of the Kimberly and Eric J. The biosimilars are here with even more coming down the pike.

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36